Last reviewed · How we verify
0.5% Ivermectin lotion
At a glance
| Generic name | 0.5% Ivermectin lotion |
|---|---|
| Sponsor | United Laboratories |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Application site pruritus
- Headache
- Eye irritation
- Vomiting
- Viral upper respiratory tract infection
- Cough
- Ocular discomfort
- Abdominal pain upper
- Nausea
- Application site dysaesthesia
- Application site laceration
- Influenza like illness
Key clinical trials
- A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice (PHASE3)
- Clinical Endpoint Study of Ivermectin 0.5% Lotion (PHASE3)
- A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% (PHASE1)
- Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos (PHASE2)
- Ivermectin in the Treatment of Head Lice (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |